Displaying items by tag: research

Human peripheral nerves — all the nerves outside of the central nervous system — are protected by the blood-nerve barrier. Researchers have detailed, for the first time, the normal human transcriptome of the blood-nerve barrier.
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.
The AMC21 School of Medicine Research Retreat met on Jan. 19, 2018, with focus on “Strategic Recruitment in the SOM.” As part of the AMC21-five-year goal to reach the top 20 in NIH funding, UAB will need to recruit a net of 80 to 84 funded faculty and retain and develop current faculty.
The School of Medicine is hosting its first Research Roundtable on Tuesday, March 13, 2018, from 7:30 a.m.-4:45 p.m. at the Sheraton Birmingham Hotel. This all-day event will spotlight the School of Medicine’s five research focus areas.
Of the 15 million people living with cancer in the United States in 2016, 62 percent were 65 years or older. A new study from researchers at the University of Alabama at Birmingham sheds light on the factors that affect health-related quality of life in older adults with cancer.
Daniel Gorelick, Ph.D., assistant professor of pharmacology and toxicology at UAB, has created zebrafish mutants in four different receptors that respond to estrogens. He has used the mutants to help unravel a novel mechanism of estrogen action on heart physiology.
Improved production of stem cells is vital if they are to achieve their promise for medical research and disease treatments like transplantation, creating patient-specific cell-replacement therapies to treat neurological diseases, heart ailments, blood diseases and diabetes.
This is the second potential diagnostic application for an investigational biomarker, and discussions are underway with industry partners to develop an assay from this UAB technology.
Page 2 of 20